Program Manager of The Covid Recovery Center at Brigham and Women’s Hospital in Boston MA. Opinions are my own. Here to advocate and educate (she/her) 💕
Boston, MA
- Tweets 5,004
- Following 3,700
- Followers 6,290
- Likes 10,259
Julie Sullivan retweeted
🦠WHN TOWN HALL: Current C0v.1d Surge -What to Expect -@jlerollblues
FRIDAY 9/25
🇺🇸2pm EDT 🇬🇧7pm BST
Register necsi-edu.zoom.us/meeting/re…
cc @LongCovidCan_Co
@snpoehlm @NoHealthNoFun @AltenbergLee @drseanmullen @jeffgilchrist @maolesen @violetaffleck19 @keetmuise @CureLongCovid
1
4
5
443
🧵💉🦠
What is the Nuvaxovid COVID vaccine and how is it different?
@paulseaman31 and I have put together a comprehensive document summarizing the available information regarding the main differences between #Nuvaxovid and the more common mRNA based #COVID vaccines. 🧪🧵1/
#Novavax
ALT Nuvaxovid protein-based nanoparticles are made of engineered proteins that help trigger an immune response ( https://www.nature.com/articles/s41541-021-00330-7 ).
5
460
RECOVER-TLC has shared the list of biomarkers they will be analyzing in their upcoming clinical trials. Their team reviewed hundreds of Long COVID studies to identify clinically promising biomarkers that were reported as dysregulated in two or more studies published in peer-reviewed journals.
1/
4
8
62
2,585
Their candidate biomarker list includes 82 priority blood biomarkers that will be studied in one or more RECOVER-TLC clinical trials. Of these, 51 biomarkers will be evaluated across all three RECOVER-TLC trials, and 31 biomarkers will be tested in specific LDN, GLP-1, or SGB treatment trials.
2/
1
1
10
383
You can view the list and more information here:
RECOVER-TLC Biomarker Studies | FNIH
fnih.org/our-programs/recove…
3/3
2
3
7
395
Julie Sullivan retweeted
Results from the @ERASE_LC trial now out.
This study had the patient voice and needs at the heart of it all.
Careful attention was given to prevent re-infection or cause a worsening of PEM throughout. Huge thanks to the team & all participants
….Now we need to do the RCT!
📢 Our paper is published in Oxford Open Immunology:
The @ERASE_LC evaluated whether a 5-day course of intravenous remdesivir is feasible, safe, and acceptable for people living with Long COVID.
This is the first study to specifically examine remdesivir as a treatment for LC.
3
7
23
1,497
After playing Sweet Briar Elementary School for the 2 games, I’m happy to see what the Gators can really do!
🧡🏈🐊💙
1
384
Julie Sullivan retweeted
Mount Sinai has joined a National Academies committee examining how SARS-CoV-2 affects cognition across the lifespan, including Long COVID, with implications for military readiness, recruitment, performance, veterans’ health, and retention.
mountsinai.org/about/newsroo…
28
66
1,979
Julie Sullivan retweeted
This compilation of peer-reviewed studies covering the impacts of COVID-19 on children has been updated. panaccindex.info/p/answered-…
5
188
415
7,702
Julie Sullivan retweeted
The arrogance of people who know almost nothing about chemistry, toxicology or biology, yet casually dismiss decades of scientific evidence, is staggering.
114
222
1,559
15,402
X definitely pushes posts about vaccines to the dark side with all the bots and trolls who for some reason, care about what other people do with their bodies, and think that liberal use of the R word is acceptable. Gross.
4
1
20
1,152
Julie Sullivan retweeted
Imagine how stupid you would sound if you kept saying "during the flu."
8
154
1,086
9,107
Some great news! Bezisterim demonstrated statistically significant improvements in 21/22 endpoints for neurocognitive and fatigue-related symptoms!
1/
Today, we announced positive results from our Phase 2 signal finding ADDRESS-LC trial evalulating bezisterim for the treatment of neurological symptoms associated with Long COVID. Read: investors.bioviepharma.com/n…
$BIVI
1
9
65
2,956
Bezisterim is moving on to phase 3 trials 🎉 and may have the potential to be the first therapy for the neurological symptoms of Long COVID.
4/
3
4
28
643
You can watch @BioVie_Pharma conference call discussing the results here: lifescievents.com/event/bkvp…
Thank you, thank you to everyone who worked on this study!
5/5
1
9
237
Julie Sullivan retweeted
Biovie is holding a webinar tomorrow at 8:30 ET on their topline results from their #LongCovid clinical trial on bezisterim!
Anyone can join: lifescievents.com/event/bkvp…
7
18
73
9,209